Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Insights are not available.
Coherent Market Insights
Gumboro Disease Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Gumboro disease also called as Infectious bursal disease (IBD) is a viral disease caused by Infectious Bursal Disease Virus (IBDV), which mostly targets the immune system of chickens. This disease was first observed in area Gumboro of Delaware, U.S.A., so called as Gu

Coherent Market Insights
Antibiotics and Corticosteroids Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Antibiotics are used to terminate the bacterial growth or bacteria itself in the case of bacterial infection, whereas, corticosteroids are used to treat the allergy and inflammatory condition. There are some functions which corticosteroids can perform while antibiotic

Coherent Market Insights
Active Pharmaceutical Ingredients Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : Mar 2018

Active Pharmaceutical Ingredients (API) are active constituents used in the manufacturing of pharmaceutical formulations and have a pharmacological and therapeutic effects on the body.  API constitutes the main ingredient, which helps cure the disease or disorder

Coherent Market Insights
Myelofibrosis Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Myelofibrosis is a bone marrow disease that interrupts the blood cells production process in the body. Fibrous or scar tissue gets developed in the bone marrow leading to scarring causing insufficient blood cell production. Myelofibrosis is a rare type of chronic leuk

Coherent Market Insights
Melanoma Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025

To Be Published : Mar 2018

Melanoma is a type of skin cancer that develops from the pigment cells known as melanocytes. It is caused due to high exposure to ultraviolet rays, which leads to sunburn, especially at high altitudes. Melanoma is categorized into three: cutaneous, mucosal, and ocular

Coherent Market Insights
Bacterial Conjunctivitis Drug Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025

To Be Published : Mar 2018

Bacterial conjunctivitis is inflammation of the outermost layer of the eye and inner area of the eyelid. Bacterial conjunctivitis symptoms include swelling, watery eyes, and redness. Bacteria responsible for conjunctivitis include staphylococci, haemophilus, Chlamydia

Coherent Market Insights
Atopic Dermatitis Drug Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025

To Be Published : Mar 2018

Atopic dermatitis, also known as eczema, is a condition in which skin becomes dry, itchy, and inflamed, which leads to redness, swelling, scaling, and crusting.  Atopic dermatitis is commonly found in children under one year. The exact cause of atopic dermatitis

Coherent Market Insights
Lung Cancer Therapeutics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Lung cancer is a malignant lung tumor, which is characterized by uncontrolled division and growth of cells in the lungs. The ability of lungs to provide oxygen into the bloodstream decreases with increasing size of tumor. The lung carcinoma is classified as, non-small

Coherent Market Insights
Mouth Ulcer Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Mouth ulcers are open lesions and sores appearing in the mucous membrane of the oral cavity. Some mouth ulcers can be severe, which need immediate medical treatment for reduction of lesion and pain severity. Increasing use of chemicals in oral products, such as toothp

Coherent Market Insights
Transdermal Drug Delivery Systems Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

A transdermal drug delivery systems (TDDS) is a medicated adhesive bandage or a patch that is stuck onto the skin to deliver a dose of drug through the skin and in the bloodstream. This patch promotes faster healing of injuries on the body, delivers a steady infusion

Coherent Market Insights
Transthyretin Amyloidosis Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Transthyretin amyloidosis is a rare disease caused due to abnormal build-up of amyloidosis in the tissues of the body. The deposits of transthyretin amyloids cause illness due to damage in structure and function of the organs and moreover, they can affect any part of

Coherent Market Insights
Familial Amyloid Cardiomyopathy Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Aggregation and deposition of mutant and wild-type transthyretin protein (TTR) in heart results in familial amyloid cardiomyopathy, which typically occur after age of 60. Familial amyloid cardiomyopathy is also known as hereditary cardiac transthyretin amyloidosis or

Coherent Market Insights
Glioblastoma Multiforme Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Glioblastoma multiforme is type of cancer which is aggressive and develops within the brain. Symptoms of glioblastoma multiforme are non-specific initially, which include headache, personality changes, nausea and also shows similar symptoms like stroke where there is

Coherent Market Insights
Migraine Drugs Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Migraine is a neurological disorder that causes severe pain in head and results in nausea, vomiting, and extreme sensitivity to light and sound. The common types of migraine are with aura and without aura that means classical migraines and common migraines. Women are

Coherent Market Insights
Cushings Syndrome Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : Mar 2018

Cushing’s syndrome is a collection of symptoms and signs, which includes high blood pressure, reddish stretch marks, abdominal obesity, round red face, weak muscles, weak bones, a fat lump between the shoulders and fragile skin that heals slowly due to prolonged

Coherent Market Insights
Women’s Health Products Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 - 2025

To Be Published : Mar 2018

Women health products provide additional nutrients and minerals to the body to increase immunity for prevention of common health issues. Women’s health is a major concern nowadays, as increasing number of women in the workforce translates to lesser time on maint

Coherent Market Insights
Hyaluronic Acid Products Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Hyaluronic acid products find wide application in anti-aging processes along with minimal invasive surgery (MIS) procedures. Hyaluronic acid, also known as hyaluronan (HA) is an organic compound that belongs to the branch of carbohydrates and polysaccharides. Hyaluron

Coherent Market Insights
Animal Healthcare Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : Mar 2018

Animal healthcare has turned its focus area by the animal medicine industry because of increase in animal disease, vaccination, animal adoption and livestock. The global animal healthcare market is expected to gain major traction, on the backdrop of increasing pet ado

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.